|
|
Article: Oxidative Stress Assay Shows Promise in Predicting Coronary Artery Disease; OXIS to Accelerate Availability of GPx Assay to Meet Growing Demand of the Research Community.
- Article from:
- Business Wire
- Article date:
- November 5, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
PORTLAND, Ore.--(BUSINESS WIRE)--Nov. 5, 2003
In an article published in the New England Journal of Medicine, scientists report that glutathione peroxidase (GPx) was a strong predictor of the risk of cardiovascular events among the 636 patients studied. OXIS International, Inc. (OTCBB:OXIS) (Noveau Marche:OXIS), one of the leading suppliers of GPx assay technology, announced today that it is accelerating availability of its OXIS cGPx-340 assay kit to meet the anticipated increase in demand of the research community fueled by the study's findings.
The GPx study was the second article featuring clinical ...